Qing Che Zuraw
Chief Development Officer · Vor Biopharma Inc.
Individual
- 2025
- Jul 17, 2025
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Qing Che Zuraw files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- RA CAPITAL MANAGEMENT, L.P. - $83.13M in VOR purchases and sales in the last 12 months
- Reprogrammed Interchange LLC - $6.49M in VOR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Qing Che Zuraw?
Qing Che Zuraw is a corporate insider, tracked as Chief Development Officer of Vor Biopharma Inc. (VOR). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Qing Che Zuraw last file a Form 4?
The only primary Form 4 on record is dated 17 July 2025.
